JP2017532005A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017532005A5 JP2017532005A5 JP2017508053A JP2017508053A JP2017532005A5 JP 2017532005 A5 JP2017532005 A5 JP 2017532005A5 JP 2017508053 A JP2017508053 A JP 2017508053A JP 2017508053 A JP2017508053 A JP 2017508053A JP 2017532005 A5 JP2017532005 A5 JP 2017532005A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- amino
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14180765.1A EP2985296A1 (en) | 2014-08-13 | 2014-08-13 | Antibodies specific for MMP9 |
| EP14180765.1 | 2014-08-13 | ||
| PCT/EP2015/068645 WO2016023979A1 (en) | 2014-08-13 | 2015-08-13 | Antibodies specific for mmp9 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017532005A JP2017532005A (ja) | 2017-11-02 |
| JP2017532005A5 true JP2017532005A5 (enExample) | 2018-09-20 |
| JP6856523B2 JP6856523B2 (ja) | 2021-04-07 |
Family
ID=51301193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017508053A Expired - Fee Related JP6856523B2 (ja) | 2014-08-13 | 2015-08-13 | Ｍｍｐ９特異的な抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10364296B2 (enExample) |
| EP (2) | EP2985296A1 (enExample) |
| JP (1) | JP6856523B2 (enExample) |
| KR (1) | KR20170041222A (enExample) |
| CN (1) | CN106573984A (enExample) |
| AU (1) | AU2015303183B2 (enExample) |
| BR (1) | BR112017002703A2 (enExample) |
| CA (1) | CA2956986A1 (enExample) |
| ES (1) | ES2784271T3 (enExample) |
| MX (1) | MX380238B (enExample) |
| PL (1) | PL3180362T3 (enExample) |
| RU (1) | RU2714043C2 (enExample) |
| WO (1) | WO2016023979A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019513737A (ja) | 2016-04-08 | 2019-05-30 | ギリアード サイエンシーズ， インコーポレイテッド | がん、炎症性疾患および自己免疫疾患を処置するための組成物および方法 |
| EP3555138A1 (en) | 2016-12-16 | 2019-10-23 | Université de Bordeaux | Mmp9 inhibitors and uses thereof in the prevention or treatment of a depigmenting disorder |
| CN110997001A (zh) * | 2017-06-02 | 2020-04-10 | 默克专利股份有限公司 | Mmp13结合免疫球蛋白 |
| US20200124604A1 (en) * | 2017-06-30 | 2020-04-23 | National Institutes Of Biomedical Innovation, Health And Nutrition | Biomarker for detecting colorectal cancer |
| KR102657653B1 (ko) * | 2017-07-18 | 2024-04-16 | 다이이찌 산쿄 가부시키가이샤 | 활성형 mmp-9 결합 펩티드 |
| EP3723770A4 (en) | 2017-12-13 | 2021-11-24 | North Carolina State University | COMPOSITIONS INCLUDING CHEMOTHERAPEUTIC AGENTS AND CHECKPOINT INHIBITORS AND METHODS OF USE |
| DK3743534T3 (da) * | 2018-01-22 | 2022-06-20 | Liquid Biopsy Res Llc | Fremgangsmåde til påvisning af coloncancer og behandlingsovervågning |
| CN108277214B (zh) * | 2018-02-23 | 2021-07-06 | 广东医科大学 | 一种应激磷酸化抗原多肽、抗体、制备方法以及应用 |
| WO2020237092A2 (en) * | 2019-05-21 | 2020-11-26 | The Regents Of The University Of California | Mmp-9 antibodies and methods of use thereof |
| CN110885375B (zh) * | 2019-12-20 | 2021-07-02 | 南京融捷康生物科技有限公司 | 特异性针对mmp-9蛋白锌离子结合结构域的单域抗体及产品与应用 |
| WO2023278491A1 (en) * | 2021-06-28 | 2023-01-05 | Releviate, Llc | Mmp-9 antibodies and uses thereof |
| JP2023021745A (ja) * | 2021-08-02 | 2023-02-14 | 学校法人東京薬科大学 | がん転移抑制のための医薬組成物 |
| CN117327186B (zh) * | 2023-07-12 | 2024-03-12 | 北京达成生物科技有限公司 | 结合mmp3蛋白的双特异性抗体及其用途 |
| EP4788430A1 (en) | 2023-10-05 | 2026-08-12 | Ashibio, Inc. | Methods and compositions for treating mmp-9 mediated disorders |
| CN117264069B (zh) * | 2023-11-23 | 2024-01-26 | 再少年(北京)生物科技有限公司 | 一种促进皮肤组织再生的工程化外泌体的制备方法及其应用 |
| CN117820488B (zh) * | 2024-01-09 | 2024-10-01 | 首都医科大学附属北京朝阳医院 | 特异性针对mmp-9的抗体对、生物材料及其应用 |
| CN117964771B (zh) * | 2024-04-02 | 2024-06-21 | 智泽童康(广州)生物科技有限公司 | 一种特异性结合mmp7的抗体、mmp7检测试剂及其应用 |
| WO2026076260A1 (en) | 2024-10-03 | 2026-04-09 | Ashibio, Inc. | Methods and compositions for mmp-9 inhibition for use with non-genetic heterotopic ossification disorders |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002235692A1 (en) * | 2001-02-23 | 2002-09-04 | Biophage Inc. | Methods and compositions for preventing and treating neutrophil-mediated diseases |
| GB0516069D0 (en) | 2005-08-04 | 2005-09-14 | Imp College Innovations Ltd | Pharmaceutical and use thereof |
| EP2155691B1 (en) * | 2007-02-23 | 2016-01-13 | Yeda Research and Development Co. Ltd. | Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| JP2011517662A (ja) * | 2008-03-03 | 2011-06-16 | ダイアックス コーポレーション | メタロプロテアーゼ９結合タンパク質 |
| US8013125B2 (en) | 2008-03-03 | 2011-09-06 | Dyax Corp. | Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| WO2010045388A2 (en) * | 2008-10-14 | 2010-04-22 | Dyax Corp. | Use of mmp-9 and mmp-12 binding proteins for the treatment and prevention of systemic sclerosis |
| WO2011028883A2 (en) * | 2009-09-03 | 2011-03-10 | Dyax Corp. | Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| WO2012027721A2 (en) * | 2010-08-27 | 2012-03-01 | Gilead Biologics, Inc | Antibodies to matrix metalloproteinase 9 |
| MD20140108A2 (ro) * | 2012-02-29 | 2015-03-31 | Gilead Biologics, Inc. | Anticorpi împotriva metaloproteinazei 9 matriciale |
| SG11201405305PA (en) | 2012-02-29 | 2014-09-26 | Gilead Biologics Inc | Antibodies to matrix metalloproteinase 9 |
-
2014
- 2014-08-13 EP EP14180765.1A patent/EP2985296A1/en not_active Withdrawn
-
2015
- 2015-08-13 PL PL15749818T patent/PL3180362T3/pl unknown
- 2015-08-13 AU AU2015303183A patent/AU2015303183B2/en not_active Ceased
- 2015-08-13 BR BR112017002703-8A patent/BR112017002703A2/pt not_active IP Right Cessation
- 2015-08-13 CN CN201580043394.1A patent/CN106573984A/zh active Pending
- 2015-08-13 CA CA2956986A patent/CA2956986A1/en not_active Abandoned
- 2015-08-13 ES ES15749818T patent/ES2784271T3/es active Active
- 2015-08-13 RU RU2017107773A patent/RU2714043C2/ru active
- 2015-08-13 WO PCT/EP2015/068645 patent/WO2016023979A1/en not_active Ceased
- 2015-08-13 JP JP2017508053A patent/JP6856523B2/ja not_active Expired - Fee Related
- 2015-08-13 EP EP15749818.9A patent/EP3180362B1/en active Active
- 2015-08-13 US US15/503,447 patent/US10364296B2/en not_active Expired - Fee Related
- 2015-08-13 KR KR1020177004988A patent/KR20170041222A/ko not_active Ceased
- 2015-08-13 MX MX2017001959A patent/MX380238B/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017107773A (ru) | Антитела, специфичные к ммр9 | |
| JP2021525546A5 (enExample) | ||
| CN104903350B (zh) | 特异于clec14a的新抗体及其用途 | |
| JP2020522261A5 (enExample) | ||
| RU2012137515A (ru) | Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения | |
| JP2010526028A5 (enExample) | ||
| JP2013506428A5 (enExample) | ||
| IL273196B2 (en) | Claudin6 antibodies and methods of treating cancer | |
| JP2014524733A5 (enExample) | ||
| RU2013153592A (ru) | Анти-mif антитела | |
| CA2777691A1 (en) | Monoclonal antibodies to progastrin and their uses | |
| JP2017534259A5 (enExample) | ||
| JP2019520034A5 (enExample) | ||
| RU2016135962A (ru) | Выделенное антитело, способ его получения, выделенная нуклеиновая кислота, экспрессионная кассета, клетка-хозяин, фармацевтический и диагностический препараты, способ лечения больного, подверженного риску или страдающего от инфекции E.COLI, и способ диагностики определения инфекций E.COLI | |
| JP2024502091A5 (enExample) | ||
| JP2023153982A (ja) | 抗プレキシンａ１アゴニスト抗体 | |
| JP2018528759A5 (enExample) | ||
| KR20250152073A (ko) | 항체, 항원 결합 단편 및 사용 방법 | |
| JP2019500855A (ja) | ヒト化抗−ｂａｇ３抗体 | |
| CN119866346B (zh) | 一种抗vegfa抗体或其抗原结合片段及其应用 | |
| RU2016106708A (ru) | Лекарственное средство, содержащее антитело к фосфолипазе d4 | |
| EP4486782A1 (en) | Anti-rage antibody | |
| TW202413422A (zh) | 抗體、其抗原結合片段及其藥物用途 | |
| TW202413405A (zh) | 抗體、其抗原結合片段及其藥物用途 | |
| CN118745226B (zh) | 抗ror1抗体及其应用 |